An experimental treatment of ocular quinine toxicity with high-dose 9-CIS beta-carotene

Retinal Cases and Brief Reports

Volumn 9, Issue 2, 2015, Pages 157-161

  Meshi, Amit ^a   Belkin, Avner ^a   Koval, Tal ^a   Kornhouser, Tom ^b   Assia, Ehud I ^a   Rotenstreich, Ygal ^b  

^a MEIR MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

9 cis beta carotene; ocular quinine toxicity; rescue therapy

Indexed keywords

BETA CAROTENE; QUININE SULFATE; ANALGESIC AGENT; QUININE; VITAMIN;

ACUTE DISEASE; ADULT; ALPHA RHYTHM; ARTICLE; B WAVE; BLINDNESS; CASE REPORT; DISEASE SEVERITY; DRUG MEGADOSE; DUNALIELLA BARDAWIL; ELECTRORETINOGRAPHY; EXPERIMENTAL THERAPY; EYE TOXICITY; FEMALE; HUMAN; INTERVENTION STUDY; PERCEPTION DISORDER; POWDER; PROGNOSIS; PUPIL DISEASE; SUICIDE ATTEMPT; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL DISORDER; VISUAL FIELD DEFECT; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY; RETINA; VISUAL FIELD;

ADMINISTRATION, ORAL; ANALGESICS, NON-NARCOTIC; BETA CAROTENE; BLINDNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRORETINOGRAPHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; MIDDLE AGED; QUININE; RETINA; SUICIDE, ATTEMPTED; VISUAL ACUITY; VISUAL FIELDS; VITAMINS;

EID: 84926302782     PISSN: 19351089     EISSN: 19371578     Source Type: Journal    
DOI: 10.1097/ICB.0000000000000125     Document Type: Article

References (10)

1. Dyson EH, Proudfoot AT, Prescott LF, et al. Death and blindness due to overdose of quinine. Br Med J (Clin Res Ed) 1985;291:31-33.
2. Guly U, Driscoll P. The management of quinine-induced blindness. Arch Emerg Med 1992;9:317-322.
3. Buchanan TA, Lyness RW, Collins AD, et al. An experimental study of quinine blindness. Eye (Lond) 1987;1:522-524.
4. Moloney JB, Hillery M, Fenton M. Two year electrophysiology follow-up in quinine amblyopia. A case report. Acta Ophthalmol 1987;65:731-734.
5. Rotenstreich Y, Harats D, Shaish A, et al. Treatment of a retinal dystrophy, fundus albipunctatus, with oral 9-cis-beta-carotene. Br J Ophthalmol 2010;94: 616-621.
6. Rotenstreich Y, Belkin M, Sadetzki S, et al. Treatment with 9-cis beta-carotene-rich powder in patients with retinitis pigmentosa: a randomized crossover trial. JAMA Ophthalmol 2013;131:985-992.
7. Brinton GS, Norton EW, Zahn JR, et al. Ocular quinine toxicity. Am J Ophthalmol 1980;90:403-410.
8. Dyson EH, Proudfoot AT, Bateman DN. Quinine amblyopia: is current management appropriate? J Toxicol Clin Toxicol 1985;23:571-578.
9. Walden J, Speckmann EJ. Effects of quinine on membrane potential and membrane currents in identified neurons of Helix pomatia. Neurosci Lett 1981;27:139-143.
10. Christoforidis J, Ricketts R, Loizos T, et al. Optical coherence tomography findings of quinine poisoning. Clin Ophthalmol 2011;5:75-80.